Alterity Therapeutics Limited (ATHE)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 09:59AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 20.53M |
| Enterprise value | 10.36M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 737.73 |
| Price/book (mrq) | 1.26 |
| Enterprise value/revenue | -1.18k |
| Enterprise value/EBITDA | -0.73 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.76 |
| 52-week change 3 | -29.61% |
| S&P500 52-week change 3 | 22.43% |
| 52-week high 3 | 5.4100 |
| 52-week low 3 | 1.5500 |
| 50-day moving average 3 | 1.9650 |
| 200-day moving average 3 | 2.3404 |
Share statistics
| Avg vol (3-month) 3 | 86.28k |
| Avg vol (10-day) 3 | 75.05k |
| Shares outstanding 5 | 8.73M |
| Implied shares outstanding 6 | 4.46M |
| Float 8 | 2.54B |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 1.00% |
| Shares short (15 Apr 2024) 4 | 90.28k |
| Short ratio (15 Apr 2024) 4 | 0.63 |
| Short % of float (15 Apr 2024) 4 | N/A |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.03% |
| Shares short (prior month 15 Mar 2024) 4 | 26.39k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 09 Jan 2023 |
Financial highlights
Currency in AUD.Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -348.40% |
Management effectiveness
| Return on assets (ttm) | -28.94% |
| Return on equity (ttm) | -53.72% |
Income statement
| Revenue (ttm) | 3.43M |
| Revenue per share (ttm) | 0.60 |
| Quarterly revenue growth (yoy) | -20.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -12.83M |
| Net income avi to common (ttm) | -12.28M |
| Diluted EPS (ttm) | -1.9900 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 12.32M |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 255.6k |
| Total debt/equity (mrq) | 1.45% |
| Current ratio (mrq) | 4.89 |
| Book value per share (mrq) | 0.01 |
Cash flow statement
| Operating cash flow (ttm) | -14.61M |
| Levered free cash flow (ttm) | -9.95M |
© 2024 Yahoo. All rights reserved.